N/A N=40 Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
Cataract
Primary: Visual Acuity at Distance (6m) logMAR — 0.00; -0.02; 0.02; 0.00 logMAR
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=35 The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
Controlling Mild to Moderate Bleeding During Surgery
Primary: Absolute Time to Hemostasis — 4.00 Minutes
N/A N=18,430 Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care
Drug Use Disorders · Illicit Drug Use · Alcohol-Related Disorders
Primary: Reach of the Digital Therapeutic to Patients in the Primary Care Clinic — 7.39; 0.73; 22.66; 15.65 Patients reached per 10000 patients — p=0.043
Phase 2 N=344 Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Metastatic BRCA Hereditary Breast Carcinoma · Metastatic Breast Carcinoma · Metastatic Malignant Neoplasm in the Brain
Primary: Progression-free Survival (PFS) — 6.4; 6.2; 4.2; 5.9 months
N/A N=351 Point of Care Diagnosis of Vaginal Infections
Vaginitis · Bacterial Vaginosis · Yeast Vaginitis
Primary: Number of Participants Prescribed Appropriate Treatment — 61; 104; 58; 21 Participants — p=<.001
N/A N=764 Cigarillo Warnings Image Sorting Study
Smoking, Cigar
Primary: Intention to Quit Smoking Cigarillos in the Next 30 Days at Weeks 2-4 — 2.47; 2.49; 2.34; 2.44 units on a scale
Phase 2 N=20 Using Mirabegron to Increase BP in Patients With POTS
Postural Orthostatic Tachycardia Syndrome · Chronic Orthostatic Intolerance · Syncope
Primary: Blood Pressure — 101; 107; 64; 68 mmHg
N/A N=64 Effects of The Pregnant Follow-Up Conducted With Home Visits on The Perinatal Outcomes
Pregnancy Related · Prenatal Care
Primary: Prenatal Education Knowledge Rate — 29.61; 21.64; 5.38; 13.35 questions — p=0.001
N/A N=12 Cryoanalgesia to Treat Phantom Limb Pain Following Above-Knee Amputation
Amputation, Surgical · Amputation, Traumatic · Phantom Limb Pain
Primary: Average Pain Intensity Change From Baseline 1 Month Post-intervention — 0; 0; 0 score on a scale
Phase 4 N=167 Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes
Ophthalmological Agent Toxicity
Primary: The Proportion of Participants Who Decreased ≥ 6 Points or the Equivalent of 20% or More in the Visual Analog Test Score Compared to Their Baseline — 74; 72 Participants
N/A N=40 tAVNS for Stress Reduction in University Students
Psychological Distress · Stress (Psychology) · Perceived Stress
Primary: Psychological Distress (K10) — 30.30; 29.5; 27.20; 27.10 Scores on a scale
N/A N=9 SurgiMend Mesh at the Hiatus
Hiatal Hernia
Primary: Recurrence Rate — 6; 3 Participants
Phase 3 N=146 A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
Friedreich Ataxia
Primary: Change From Baseline in the mFARS Score at Week 72 - Modified Intent-to-treat (mITT) Analysis Set — 1.218; 2.828 units on a scale — p== 0.1440
N/A N=235 Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention
Prescription Drug Abuse (Not Dependent) · Intentional Misuse
Primary: Frequency of Prescription Stimulant Diversion — .25; .41; .18; .30 Mean number of times diverted — p=.499
Phase 2 N=12 LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
Metastatic Pancreatic Adenocarcinoma
Primary: Phase I: Determine the Recommended Phase II Dose (RP2D) — 300 mg